As of October 31, 2025, Scancell Holdings PLC. carries a market capitalization of 122.04M, placing it among publicly traded companies globally. Its enterprise value stands at 132.02M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 122.04M |
| Enterprise Value | 132.02M |
Scancell Holdings PLC.'s next confirmed earnings release is scheduled for February 4, 2027.
| Earnings Date | 2/4/2027 |
As of October 31, 2025, Scancell Holdings PLC. has 1.04B shares outstanding.
| Shares Outstanding | 1.04B |
These figures are as of October 31, 2025.
| PB Ratio | -11.12 |
| P/TBV Ratio | -9.32 |
As of October 31, 2025, Scancell Holdings PLC. maintains a current ratio of 0.56, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.56 |
| Quick Ratio | 0.36 |
| Debt / Equity | -193.29 |
As of the close on September 9, 2026, Scancell Holdings PLC.'s stock has gained approximately 9.39% over the past 52 weeks.
| 52-Week Price Change | 9.39% |
| 50-Day Moving Average | 0.17 |
As of October 31, 2025, Scancell Holdings PLC. holds 11.24M in cash and equivalents against 21.21M in total debt, resulting in a net debt position of 9.55M. Total book value stands at -10.97M, with working capital of -13.74M providing operational flexibility.
| Cash & Cash Equivalents | 11.24M |
| Total Debt | 21.21M |
| Net Debt | 9.55M |
| Equity (Book Value) | -10.97M |
| Book Value Per Share | -0.01 |
| Working Capital | -13.74M |
Scancell Holdings PLC.'s most recent stock split took place on October 13, 2020.
| Last Split Date | 10/13/2020 |
Already premium?